Jump Financial’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
SCM
QCM
Jump Financial's NVCR Position: Q2 2026 in Review
Jump Financial reduced its NovoCure (NVCR) stake by 15% in Q2 2026, selling an estimated $863K and leaving 311,349 shares worth $4.72M. The position accounts for 0.04% of the portfolio, ranked #543.
Jump Financial first reported a position in NVCR in Q3 2020 and has held it in 18 quarters since. The position peaked at $7.26M in Q4 2025. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.
- Jump Financial held 311,349 shares of NovoCure worth $4.72M as of Q2 2026.
- Jump Financial sold 57,028 NovoCure shares in Q2 2026, an estimated $863K.
- NovoCure made up 0.04% of Jump Financial's portfolio in Q2 2026, its #543 holding.
- Jump Financial first reported a position in NovoCure in Q3 2020 and has held it in 18 quarters since.
- Jump Financial's NovoCure position peaked at $7.26M in Q4 2025.
- 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.
Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.